- Erenumab2018 | Third Faculty of Medicine
- Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men2021 | First Faculty of Medicine, Central Library of Charles University
- Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Hodnocení účinnosti a bezpečnosti déletrvající léčby erenumabem - výsledky pětiletého otevřeného sledování2021 | Third Faculty of Medicine
- CGRP monoclonal antibodies for migraine prophylaxis2019 | First Faculty of Medicine
- CGRP antibodies in the prophylactic treatment of migraine2022 | First Faculty of Medicine
- News from the EAN Congress 2021 Migraine treatment in the world of evidence-based medicine2021 | Third Faculty of Medicine
- From pathophysiology of migraine to monoclonal antibodies2019 | Faculty of Medicine in Pilsen
- Primary headaches - treatment today and tomorrow2018 | Faculty of Medicine in Pilsen
- Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index2022 | First Faculty of Medicine, Faculty of Physical Education and Sport